| Year |
Citation |
Score |
| 2023 |
Bailey JT, Moshkani S, Rexhouse C, Cimino JL, Robek MD. CD4 T cells reverse surface antigen persistence in a mouse model of HBV replication. Microbiology Spectrum. e0344723. PMID 37948314 DOI: 10.1128/spectrum.03447-23 |
0.409 |
|
| 2023 |
Schmidt S, Mengistu M, Daffis S, Ahmadi-Erber S, Deutschmann D, Grigoriev T, Chu R, Leung C, Tomkinson A, Uddin MN, Moshkani S, Robek MD, Perry J, Lauterbach H, Orlinger K, et al. Alternating arenavirus vector immunization generates robust polyfunctional genotype cross-reactive HBV-specific CD8 T cell responses and high anti-HBs titers. The Journal of Infectious Diseases. PMID 37602681 DOI: 10.1093/infdis/jiad340 |
0.391 |
|
| 2021 |
Chiale C, Marchese AM, Furuya Y, Robek MD. Virus-based vaccine vectors with distinct replication mechanisms differentially infect and activate dendritic cells. Npj Vaccines. 6: 138. PMID 34811393 DOI: 10.1038/s41541-021-00400-w |
0.431 |
|
| 2021 |
Chiale C, Marchese AM, Robek MD. Innate immunity and HBV persistence. Current Opinion in Virology. 49: 13-20. PMID 33992859 DOI: 10.1016/j.coviro.2021.04.003 |
0.322 |
|
| 2020 |
Chiale C, Yarovinsky TO, Mason SW, Madina BR, Menon M, Krady MM, Moshkani S, Chattopadhyay Pal A, Almassian B, Rose JK, Robek MD, Nakaar V. Modified Alphavirus-Vesiculovirus Hybrid Vaccine Vectors for Homologous Prime-Boost Immunotherapy of Chronic Hepatitis B. Vaccines. 8. PMID 32517032 DOI: 10.3390/Vaccines8020279 |
0.305 |
|
| 2019 |
Yarovinsky TO, Mason SW, Menon M, Krady MM, Haslip M, Madina BR, Ma X, Moshkani S, Chiale C, Pal AC, Almassian B, Rose JK, Robek MD, Nakaar V. Virus-like Vesicles Expressing Multiple Antigens for Immunotherapy of Chronic Hepatitis B. Iscience. 21: 391-402. PMID 31704650 DOI: 10.1016/J.Isci.2019.10.040 |
0.355 |
|
| 2019 |
Marchese AM, Chiale C, Moshkani S, Robek MD. Mechanisms of Innate Immune Activation by a Hybrid Alphavirus-Rhabdovirus Vaccine Platform. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. PMID 31633442 DOI: 10.1089/jir.2019.0123 |
0.403 |
|
| 2019 |
Chiale C, Moshkani S, Rose JK, Robek MD. Heterologous prime-boost immunization with vesiculovirus-based vectors expressing HBV core antigen induces CD8 T cell responses in naïve and persistently infected mice and protects from challenge. Antiviral Research. PMID 31153968 DOI: 10.1016/J.Antiviral.2019.05.014 |
0.42 |
|
| 2018 |
Moshkani S, Chiale C, Lang SM, Rose JK, Robek MD. A highly attenuated vesicular stomatitis virus-based vaccine platform controls HBV replication in mouse models of hepatitis B. Journal of Virology. PMID 30541859 DOI: 10.1128/Jvi.01586-18 |
0.438 |
|
| 2017 |
Reynolds TD, Moshkani S, Robek MD. An ELISPOT-Based Assay to Measure HBV-Specific CD8(+) T Cell Responses in Immunocompetent Mice. Methods in Molecular Biology (Clifton, N.J.). 1540: 237-247. PMID 27975322 DOI: 10.1007/978-1-4939-6700-1_20 |
0.422 |
|
| 2015 |
Reynolds TD, Buonocore L, Rose NF, Rose JK, Robek MD. Virus-Like Vesicle-Based Therapeutic Vaccine Vectors for Chronic Hepatitis B Virus Infection. Journal of Virology. 89: 10407-15. PMID 26246574 DOI: 10.1128/Jvi.01184-15 |
0.504 |
|
| 2014 |
Ding S, Robek MD. Peroxisomal MAVS activates IRF1-mediated IFN-λ production. Nature Immunology. 15: 700-1. PMID 25045870 DOI: 10.1038/Ni.2924 |
0.435 |
|
| 2014 |
Guayasamin RC, Reynolds TD, Wei X, Fujiwara M, Robek MD. Type III interferon attenuates a vesicular stomatitis virus-based vaccine vector. Journal of Virology. 88: 10909-17. PMID 25008938 DOI: 10.1128/Jvi.01910-14 |
0.49 |
|
| 2014 |
van den Pol AN, Ding S, Robek MD. Long-distance interferon signaling within the brain blocks virus spread. Journal of Virology. 88: 3695-704. PMID 24429359 DOI: 10.1128/Jvi.03509-13 |
0.389 |
|
| 2014 |
Ding S, Khoury-Hanold W, Iwasaki A, Robek MD. Epigenetic reprogramming of the type III interferon response potentiates antiviral activity and suppresses tumor growth. Plos Biology. 12: e1001758. PMID 24409098 DOI: 10.1371/Journal.Pbio.1001758 |
0.418 |
|
| 2014 |
Bolen CR, Ding S, Robek MD, Kleinstein SH. Dynamic expression profiling of type I and type III interferon-stimulated hepatocytes reveals a stable hierarchy of gene expression. Hepatology (Baltimore, Md.). 59: 1262-72. PMID 23929627 DOI: 10.1002/Hep.26657 |
0.441 |
|
| 2013 |
Garcia ML, Reynolds TD, Mothes W, Robek MD. Functional characterization of the putative hepatitis B virus core protein late domain using retrovirus chimeras. Plos One. 8: e72845. PMID 24009707 DOI: 10.1371/Journal.Pone.0072845 |
0.42 |
|
| 2013 |
Cobleigh MA, Wei X, Robek MD. A vesicular stomatitis virus-based therapeutic vaccine generates a functional CD8 T cell response to hepatitis B virus in transgenic mice. Journal of Virology. 87: 2969-73. PMID 23269785 DOI: 10.1128/Jvi.02111-12 |
0.476 |
|
| 2013 |
Cobleigh MA, Robek MD. Protective and pathological properties of IL-22 in liver disease: implications for viral hepatitis. The American Journal of Pathology. 182: 21-8. PMID 23159948 DOI: 10.1016/J.Ajpath.2012.08.043 |
0.42 |
|
| 2013 |
Bolen CR, Robek MD, Brodsky L, Schulz V, Lim JK, Taylor MW, Kleinstein SH. The blood transcriptional signature of chronic hepatitis C virus is consistent with an ongoing interferon-mediated antiviral response. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 33: 15-23. PMID 23067362 DOI: 10.1089/Jir.2012.0037 |
0.401 |
|
| 2012 |
Cobleigh MA, Bradfield C, Liu Y, Mehta A, Robek MD. The immune response to a vesicular stomatitis virus vaccine vector is independent of particulate antigen secretion and protein turnover rate. Journal of Virology. 86: 4253-61. PMID 22345454 DOI: 10.1128/Jvi.05991-11 |
0.419 |
|
| 2012 |
Reynolds T, Guayasamin R, Fujiwara M, Robek M. O004 Using type III interferon to improve the efficacy of vaccine and oncolytic viral vectors Cytokine. 59: 498. DOI: 10.1016/J.Cyto.2012.06.030 |
0.494 |
|
| 2011 |
Zhang Y, Cobleigh MA, Lian JQ, Huang CX, Booth CJ, Bai XF, Robek MD. A proinflammatory role for interleukin-22 in the immune response to hepatitis B virus. Gastroenterology. 141: 1897-906. PMID 21708106 DOI: 10.1053/J.Gastro.2011.06.051 |
0.455 |
|
| 2010 |
Pagliaccetti NE, Robek MD. Interferon-λ in HCV Infection and Therapy. Viruses. 2: 1589-602. PMID 21994696 DOI: 10.3390/V2081589 |
0.383 |
|
| 2010 |
Pagliaccetti NE, Robek MD. Interferon-lambda in the immune response to hepatitis B virus and hepatitis C virus. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 30: 585-90. PMID 20645875 DOI: 10.1089/Jir.2010.0060 |
0.469 |
|
| 2010 |
Cobleigh MA, Buonocore L, Uprichard SL, Rose JK, Robek MD. A vesicular stomatitis virus-based hepatitis B virus vaccine vector provides protection against challenge in a single dose. Journal of Virology. 84: 7513-22. PMID 20504927 DOI: 10.1128/Jvi.00200-10 |
0.442 |
|
| 2010 |
Pagliaccetti NE, Chu EN, Bolen CR, Kleinstein SH, Robek MD. Lambda and alpha interferons inhibit hepatitis B virus replication through a common molecular mechanism but with different in vivo activities. Virology. 401: 197-206. PMID 20303135 DOI: 10.1016/J.Virol.2010.02.022 |
0.469 |
|
| 2010 |
Bandi P, Pagliaccetti NE, Robek MD. Inhibition of type III interferon activity by orthopoxvirus immunomodulatory proteins. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 30: 123-34. PMID 20038204 DOI: 10.1089/Jir.2009.0049 |
0.46 |
|
| 2010 |
Bandi P, Garcia ML, Booth CJ, Chisari FV, Robek MD. Bortezomib inhibits hepatitis B virus replication in transgenic mice. Antimicrobial Agents and Chemotherapy. 54: 749-56. PMID 19949053 DOI: 10.1128/Aac.01101-09 |
0.483 |
|
| 2010 |
Zhang Y, Lian JQ, Huang CX, Wang JP, Wei X, Nan XP, Yu HT, Jiang LL, Wang XQ, Zhuang Y, Li XH, Li Y, Wang PZ, Robek MD, Bai XF. Overexpression of Toll-like receptor 2/4 on monocytes modulates the activities of CD4(+)CD25(+) regulatory T cells in chronic hepatitis B virus infection. Virology. 397: 34-42. PMID 19945134 DOI: 10.1016/J.Virol.2009.11.007 |
0.371 |
|
| 2010 |
Zhang Y, Cobleigh MA, Lian J, Huang C, Bai X, Robek MD. SS11-6 A Proinflammatory role for IL-22 in acute hepatitis B Cytokine. 52: 81. DOI: 10.1016/J.Cyto.2010.07.337 |
0.308 |
|
| 2009 |
Garcia ML, Byfield R, Robek MD. Hepatitis B virus replication and release are independent of core lysine ubiquitination. Journal of Virology. 83: 4923-33. PMID 19244316 DOI: 10.1128/Jvi.02644-08 |
0.425 |
|
| 2009 |
Bandi P, Maes N, Han M, den Pol A, Robek MD. Type III interferon activity in the brain Cytokine. 48: 136. DOI: 10.1016/J.Cyto.2009.07.577 |
0.302 |
|
| 2009 |
Bandi P, Pagliaccetti NE, Robek MD. Inhibition of type III interferon activity by poxvirus immunomodulatory proteins Cytokine. 48: 62. DOI: 10.1016/J.Cyto.2009.07.197 |
0.357 |
|
| 2008 |
Pagliaccetti NE, Eduardo R, Kleinstein SH, Mu XJ, Bandi P, Robek MD. Interleukin-29 functions cooperatively with interferon to induce antiviral gene expression and inhibit hepatitis C virus replication. The Journal of Biological Chemistry. 283: 30079-89. PMID 18757365 DOI: 10.1074/Jbc.M804296200 |
0.486 |
|
| 2007 |
Ying C, Li Y, Leung CH, Robek MD, Cheng YC. Unique antiviral mechanism discovered in anti-hepatitis B virus research with a natural product analogue. Proceedings of the National Academy of Sciences of the United States of America. 104: 8526-31. PMID 17488817 DOI: 10.1073/Pnas.0609883104 |
0.489 |
|
| 2007 |
Wollmann G, Robek MD, van den Pol AN. Variable deficiencies in the interferon response enhance susceptibility to vesicular stomatitis virus oncolytic actions in glioblastoma cells but not in normal human glial cells. Journal of Virology. 81: 1479-91. PMID 17108037 DOI: 10.1128/Jvi.01861-06 |
0.452 |
|
| 2007 |
Robek MD, Garcia ML, Boyd BS, Chisari FV. Role of immunoproteasome catalytic subunits in the immune response to hepatitis B virus. Journal of Virology. 81: 483-91. PMID 17079320 DOI: 10.1128/Jvi.01779-06 |
0.532 |
|
| 2007 |
van den Pol AN, Robek MD, Ghosh PK, Ozduman K, Bandi P, Whim MD, Wollmann G. Cytomegalovirus induces interferon-stimulated gene expression and is attenuated by interferon in the developing brain. Journal of Virology. 81: 332-48. PMID 17065212 DOI: 10.1128/Jvi.01592-06 |
0.388 |
|
| 2006 |
Publicover J, Ramsburg E, Robek M, Rose JK. Rapid pathogenesis induced by a vesicular stomatitis virus matrix protein mutant: viral pathogenesis is linked to induction of tumor necrosis factor alpha. Journal of Virology. 80: 7028-36. PMID 16809308 DOI: 10.1128/Jvi.00478-06 |
0.344 |
|
| 2005 |
Ramsburg E, Publicover J, Buonocore L, Poholek A, Robek M, Palin A, Rose JK. A vesicular stomatitis virus recombinant expressing granulocyte-macrophage colony-stimulating factor induces enhanced T-cell responses and is highly attenuated for replication in animals. Journal of Virology. 79: 15043-53. PMID 16306575 DOI: 10.1128/Jvi.79.24.15043-15053.2005 |
0.503 |
|
| 2005 |
Isogawa M, Robek MD, Furuichi Y, Chisari FV. Toll-like receptor signaling inhibits hepatitis B virus replication in vivo. Journal of Virology. 79: 7269-72. PMID 15890966 DOI: 10.1128/Jvi.79.11.7269-7272.2005 |
0.396 |
|
| 2005 |
Robek MD, Boyd BS, Chisari FV. Lambda interferon inhibits hepatitis B and C virus replication. Journal of Virology. 79: 3851-4. PMID 15731279 DOI: 10.1128/Jvi.79.6.3851-3854.2005 |
0.463 |
|
| 2004 |
Robek MD, Boyd BS, Wieland SF, Chisari FV. Signal transduction pathways that inhibit hepatitis B virus replication. Proceedings of the National Academy of Sciences of the United States of America. 101: 1743-7. PMID 14757813 DOI: 10.1073/Pnas.0308340100 |
0.476 |
|
| 2002 |
Robek MD, Wieland SF, Chisari FV. Inhibition of hepatitis B virus replication by interferon requires proteasome activity. Journal of Virology. 76: 3570-4. PMID 11884582 DOI: 10.1128/Jvi.76.7.3570-3574.2002 |
0.487 |
|
| 2001 |
Ratner L, Portis T, Robek M, Harding J, Grossman W. Studies of the immortalizing activity of HTLV type 1 Tax, using an infectious molecular clone and transgenic mice. Aids Research and Human Retroviruses. 16: 1647-51. PMID 11080805 DOI: 10.1089/08892220050193092 |
0.549 |
|
| 2000 |
Robek MD, Ratner L. Immortalization of T lymphocytes by human T-cell leukemia virus type 1 is independent of the tax-CBP/p300 interaction. Journal of Virology. 74: 11988-92. PMID 11090202 DOI: 10.1128/Jvi.74.24.11988-11992.2000 |
0.605 |
|
| 2000 |
Bartoe JT, Albrecht B, Collins ND, Robek MD, Ratner L, Green PL, Lairmore MD. Functional role of pX open reading frame II of human T-lymphotropic virus type 1 in maintenance of viral loads in vivo. Journal of Virology. 74: 1094-100. PMID 10627519 DOI: 10.1128/Jvi.74.3.1094-1100.2000 |
0.534 |
|
| 1999 |
Collins ND, D'Souza C, Albrecht B, Robek MD, Ratner L, Ding W, Green PL, Lairmore MD. Proliferation response to interleukin-2 and Jak/Stat activation of T cells immortalized by human T-cell lymphotropic virus type 1 is independent of open reading frame I expression. Journal of Virology. 73: 9642-9. PMID 10516077 DOI: 10.1128/Jvi.73.11.9642-9649.1999 |
0.589 |
|
| 1999 |
Robek MD, Ratner L. Immortalization of CD4(+) and CD8(+) T lymphocytes by human T-cell leukemia virus type 1 Tax mutants expressed in a functional molecular clone. Journal of Virology. 73: 4856-65. PMID 10233947 DOI: 10.1128/Jvi.73.6.4856-4865.1999 |
0.609 |
|
| 1999 |
Robek MD, Ratner L. ROLE OF TAX ACTIVATION OF CELLULAR PROMOTERS IN IMMORTALIZATION OF T-LYMPHOCYTES BY HTLV-I Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 20: A34. DOI: 10.1097/00042560-199904010-00122 |
0.528 |
|
| 1998 |
Robek MD, Wong FH, Ratner L. Human T-cell leukemia virus type 1 pX-I and pX-II open reading frames are dispensable for the immortalization of primary lymphocytes. Journal of Virology. 72: 4458-62. PMID 9557741 DOI: 10.1128/Jvi.72.5.4458-4462.1998 |
0.62 |
|
| 1995 |
Steagall WK, Robek MD, Perry ST, Fuller FJ, Payne SL. Incorporation of uracil into viral DNA correlates with reduced replication of EIAV in macrophages. Virology. 210: 302-13. PMID 7542416 DOI: 10.1006/Viro.1995.1347 |
0.374 |
|
| Show low-probability matches. |